Acorda Therapeutics, Inc. (ACOR) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist SCOPIA CAPITAL MANAGEMENT LP mit 4,750,219 Aktien. Weitere bedeutende Anteilseigner sind PHILLIPS BARCLAY A und COHEN RON.
ACOR Insider-Beteiligungen
Größter Aktionär
SCOPIA CAPITAL MANAGEMENT LP
4,750,219 Aktien
Käufe (12 Monate)
0
$0.00 Wert
Verkäufe (12 Monate)
0
$0.00 Wert
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Scopia Capital Management Lp |
10 Percent Owner |
4,750,219 |
2019-02-01 |
|
| 2 |
Phillips Barclay A |
Director |
333,419 |
2008-06-16 |
|
| 3 |
Cohen Ron |
President and CEO |
168,800 |
2023-04-04 |
|
| 4 |
Wasman Jane |
President, Intl and Gc |
117,420 |
2019-12-04 |
|
| 5 |
Gesser Michael A |
Chief Financial Officer |
85,000 |
2021-11-09 |
|
| 6 |
Belloff Neil S. |
General Counsel and Corp Secy |
77,300 |
2023-04-04 |
|
| 7 |
Clem Kerry M |
Chief Commercial Officer |
77,300 |
2023-04-04 |
|
| 8 |
Batycky Richard P. |
Chief Tech. Off. & Site Head |
55,513 |
2018-02-26 |
|
| 9 |
Carrazana Enrique J. |
Chief Medical Officer |
32,148 |
2015-12-03 |
|
| 10 |
Wessel Thomas |
Chief Medical Officer |
26,250 |
2011-03-07 |
|
| 11 |
Rogers Michael W |
Chief Financial Officer |
20,000 |
2016-05-13 |
|
| 12 |
Blank Burkhard |
CMO and Head of R&d |
18,527 |
2021-03-05 |
|
| 13 |
Hindman Andrew A. |
Chief Business Officer |
15,075 |
2019-03-12 |
|
| 14 |
Smith Ian F |
Director |
15,000 |
2018-06-29 |
|
| 15 |
Rauscher Steven M |
Director |
15,000 |
2020-06-17 |
|
| 16 |
Lawrence David |
Chief, Bus. Ops & Pao |
13,811 |
2020-12-03 |
|
| 17 |
Sabella Lauren M |
Chief Operating Officer |
10,710 |
2022-09-07 |
|
| 18 |
Strader Catherine D. |
Director |
10,000 |
2021-06-04 |
|
| 19 |
Greene Barry E |
Director |
10,000 |
2021-06-04 |
|
| 20 |
Randall Lorin |
Director |
10,000 |
2022-06-14 |
|
Keine Beteiligungsdaten für ACOR verfügbar.
